Application of the gas chromatography-mass spectrometry method for the identification of standard samples of ACE inhibitors drugs
- Authors: Chepilo D.A.1, Gegechkori V.I.1,2, Shchepochkina O.Y.1, Chadova N.N.3, Levko A.A.3, Shestakov V.N.3
-
Affiliations:
- Sechenov First Moscow State Medical University (Sechenov University)
- Peoples' Friendship University of Russia
- State Institute of Drugs and Good Practices and Good Practices
- Issue: Vol 71, No 3 (2022)
- Pages: 34-41
- Section: Articles
- URL: https://journals.eco-vector.com/0367-3014/article/view/113706
- DOI: https://doi.org/10.29296/25419218-2022-03-06
- ID: 113706
Cite item
Open Access
Access granted
Abstract
Introduction. To date, quality control and standardization of drugs, including medicines from the group of angiotensin-converting enzyme inhibitors (ACE inhibitors), as a rule, involves the use of reference standards (RS). In the process of RS development, a number of comprehensive tests are carried out in compliance with the requirements governing the quality of standards. One of the key values of RS quality is the definition of authenticity. Objective: to study the possibility of using the chromatography-mass spectrometric method to determine the identity of RS of antihypertensive medicines of the ACE inhibitor group. Material and methods. As part of the development of RS, the investigated samples of Captopril and Enalapril maleate substances were used. Chromatography-mass spectra of solutions of the studied samples were recorded on a Zhimadzu Nexera liquid chromatograph with a Shimadzu LCMS-8050 mass-selective detector using the following types of ionization - APCI and HESI. Results. The reliability, high sensitivity, accuracy, the informational content of the mass spectrometric method is shown on the example of the identification of the developed RS of Captopril and Enalapril maleate. The determination of the molecular ion and the study of the fragmentation scheme of the main molecular ions in the mass spectra allows us to successfully identify the studied samples of Captopril and Enalapril maleate. Conclusion. Experimental data obtained during the study of samples of Captopril and Enalapril maleate can be used both in quality control of the corresponding RS and in the pharmaceutical analysis of medicinal products containing the same pharmaceutical substances.
Full Text
About the authors
Dmitry Andreevich Chepilo
Sechenov First Moscow State Medical University (Sechenov University)
Author for correspondence.
Email: z22dima@mail.ru
Ph.D. student of the Department of pharmaceutical and toxicological chemistry named after A.P. Arzamastsev, Institute of pharmacy named after A.P. Nelyubin
Vladimir Iraklievich Gegechkori
Sechenov First Moscow State Medical University (Sechenov University); Peoples' Friendship University of Russia
Email: vgegechkori@gmail.com
Ph.D. in pharmaceutical sciences, associate professor of the Department of pharmaceutical and toxicological chemistry named after A.P. Arzamastsev, Institute of pharmacy named after A.P. Nelyubin; senior teacher of the department of microbiology and virology, faculty of medicine
Olga Yuryevna Shchepochkina
Sechenov First Moscow State Medical University (Sechenov University)
Email: shchepochkina_o_yu@staff.sechenov.ru
Ph.D. in pharmaceutical sciences, associate professor of the Department of pharmaceutical and toxicological chemistry named after A.P. Arzamastsev, Institute of pharmacy named after A.P. Nelyubin
Natalia Nikolaevna Chadova
State Institute of Drugs and Good Practices and Good Practices
Email: chadovann@gilsinp.ru
Ph.D. of chemical sciences, head of the department for inspection of production of medicines and expertise
Anatolii Anatolevich Levko
State Institute of Drugs and Good Practices and Good Practices
Email: levko.aa@gilsinp.ru
Ph.D. of medical sciences, deputy head of the department for inspection of production of medicines and expertise
Vladislav Nikolaevich Shestakov
State Institute of Drugs and Good Practices and Good Practices
Email: shestakov@gilsinp.ru
director
References
- Grbovic G., Trebse P., Dolenc D., Lebedev A.T., Sarakha M. LC/MS study of the UV filter hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]- benzoate (DHHB) aquatic chlorination with sodium hypochlorite. JMS. 2013; 48 (11): 1232-40. DOI: 10.1002/ jms.3286.
- Kupriyanova O.V., Milyukov V.A., Shevyrin V.A., Shafran Y.M., Rusinov V.L., Lebedev A.T. Synthesis and determination of analytical characteristics and differentiation of positional isomers in the series of n-(2-methoxybenzyl)-2-(dimethoxyphenyl)ethanamine using chromatography-mass spectrometry. Drug Test. Anal. 2020; 12 (8): 1154-70. DOI: 10.1002/ dta.2859.
- Государственная Фармакопея Российской Федерации, XIV изд., том I, ОФС.1.1.0007.18 «Стандартные образцы». [Электронное издание]. Режим доступа: https://femb.ru/record/pharmacopea14. [Дата обращения 23 Марта, 2022].
- Меркулов В.А., Саканян E.K, Климов В.И. и др. Современные подходы к разработке стандартных образцов для оценки качества фармацевтических субстанций. Химико-фармацевтический журнал. 2015; 49 (11): 54-6. doi: 10.30906/0023-1134-2015-49-11-54-56.
- Гегечкори В.И., Шульга Н.А., Щепочкина О.Ю. и др. Методика идентификации материала стандартного образца состава азитромицина с использованием спектральных методов. Эталоны. Стандартные образцы. 2021; 17 (3): 21-4. doi: 10.20915/2687-08862021-17-3-21-34.
- Меркулов В.А., Саканян E.K, Волкова Р.А. Фармакопейные стандартные образцы и практика их применения в отечественной системе стандартизации лекарственных средств. Химикофармацевтический журнал. 2016; 50 (4): 40-3. doi: 10.30906/0023-11342016-50-4-40-43.
- Гегечкори В. И., Щепочкина О. Ю., Грушевская Л. Н. и др. Применение спектральных методов при разработке стандартных образцов для лекарственных средств пептидной структуры. Фармация. 2016, 63 (1): 3-6. DOI: отсутствует.
- Кутин А.А., Мастеркова Т.В., Яшкир В.А. и др. Хромато-масс-спектрометрия: использование для идентификации лекарственных субстанций и примесей. Ведомости НЦЭСМП. 2013; 2: 12-4. DOI: отсутствует.
- Щепочкина О.Ю., Гегечкори В.И., Прокофьева В.И. и др. Современные подходы к разработке стандартных образцов лекарственных средств. Химико-фармацевтический журнал. 2020; 54 (7): 49-54. doi: 10.30906/0023-1134-202054-7-49-54.
- Государственная Фармакопея Российской Федерации, издание XIV, том III, ФС.2.1.0106.18 «каптоприл». [Электронное издание]. Режим доступа: https://femb.ru/record/pharmacopea14. [Дата обращения 23 Марта, 2022].
- Государственная Фармакопея Российской Федерации, издание XIV, том III, ФС.2.1.0045.15 «эналаприла малеат». [Электронное издание]. Режим доступа: https://femb.ru/record/pharmacopea14. [Дата обращения 23 Марта, 2022].
- Романов Б.К., Преферанская Н.Г., Чубарев В.Н. Средства, снижающие активность ренин-ангиотензин-альдостероновой системы. Российский медицинский журнал. 2012; 18 (3): 44-9.
Supplementary files
